MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,592,000 | -34.3% | 9,000 | -40.0% | 0.01% | -33.3% |
| Q2 2021 | $2,422,000 | -46.0% | 15,000 | -42.7% | 0.01% | -47.1% |
| Q1 2021 | $4,488,000 | +84.1% | 26,200 | +136.0% | 0.02% | +88.9% |
| Q4 2020 | $2,438,000 | +133.1% | 11,100 | +76.2% | 0.01% | +125.0% |
| Q3 2020 | $1,046,000 | +66.8% | 6,300 | +14.5% | 0.00% | +33.3% |
| Q2 2020 | $627,000 | +202.9% | 5,500 | +103.7% | 0.00% | +200.0% |
| Q1 2020 | $207,000 | -33.0% | 2,700 | +12.5% | 0.00% | 0.0% |
| Q4 2019 | $309,000 | +33.2% | 2,400 | -20.0% | 0.00% | 0.0% |
| Q3 2019 | $232,000 | +50.6% | 3,000 | +100.0% | 0.00% | 0.0% |
| Q2 2019 | $154,000 | +83.3% | 1,500 | -68.8% | 0.00% | – |
| Q3 2014 | $84,000 | +75.0% | 4,800 | +100.0% | 0.00% | – |
| Q2 2014 | $48,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |